{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:37:57Z","timestamp":1777678677689,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.seizure.2013.03.006","type":"journal-article","created":{"date-parts":[[2013,4,29]],"date-time":"2013-04-29T12:45:43Z","timestamp":1367239543000},"page":"462-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Levetiracetam but not valproate inhibits function of CD8+ T lymphocytes"],"prefix":"10.1016","volume":"22","author":[{"given":"Gang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareike","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Stei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Allenh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Waschbisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Tackenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"H\u00f6llerhage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter U.","family":"H\u00f6glinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Wegner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang H.","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Rosenow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajo M.","family":"Hamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2013.03.006_bib0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/08830738050200020101","article-title":"Levetiracetam in pediatrics","volume":"20","author":"Vigevano","year":"2005","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.seizure.2013.03.006_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1527-3458.2007.00005.x","article-title":"Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug","volume":"13","author":"De Smedt","year":"2007","journal-title":"CNS Drug Reviews"},{"key":"10.1016\/j.seizure.2013.03.006_bib0015","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.seizure.2013.03.006_bib0020","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000mg\/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2013.03.006_bib0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2013.03.006_bib0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/seiz.2000.0380","article-title":"A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000mg daily and 4000mg daily, without titration in patients with refractory epilepsy","volume":"9","author":"Betts","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2013.03.006_bib0035","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures","volume":"41","author":"Shorvon","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2013.03.006_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(01)00202-9","article-title":"A systematic review of the safety profile of levetiracetam: a new antiepileptic drug","volume":"47","author":"French","year":"2001","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2013.03.006_bib0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1528-1167.2001.00008.x","article-title":"Safety profile of levetiracetam","volume":"42","author":"Harden","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2013.03.006_bib0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbi.2010.10.022","article-title":"Interictal alterations of cytokines and leukocytes in patients with active epilepsy","volume":"25","author":"Nowak","year":"2011","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.seizure.2013.03.006_bib0055","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.4049\/jimmunol.172.10.6407","article-title":"The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration","volume":"172","author":"Betts","year":"2004","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.seizure.2013.03.006_bib0060","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1126\/science.2431484","article-title":"CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication","volume":"234","author":"Walker","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.seizure.2013.03.006_bib0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/328345a0","article-title":"HIV-specific cytotoxic T lymphocytes in seropositive individuals","volume":"328","author":"Walker","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.seizure.2013.03.006_bib0070","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nri1254","article-title":"Human CD8(+) T-cell differentiation in response to viruses","volume":"3","author":"Van Lier","year":"2003","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.seizure.2013.03.006_bib0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.immuni.2007.08.007","article-title":"Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection","volume":"27","author":"Kaech","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.seizure.2013.03.006_bib0080","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2013.03.006_bib0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0145-2126(01)00151-5","article-title":"Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways","volume":"26","author":"Kawagoe","year":"2002","journal-title":"Leukemia Research"},{"key":"10.1016\/j.seizure.2013.03.006_bib0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.21552","article-title":"The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia","volume":"106","author":"Kuendgen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.seizure.2013.03.006_bib0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2119\/2007-00084.Bokelmann","article-title":"Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteins","volume":"14","author":"Bokelmann","year":"2008","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.seizure.2013.03.006_bib0100","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.4049\/jimmunol.180.12.8102","article-title":"Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B)","volume":"180","author":"Araki","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.seizure.2013.03.006_bib0105","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.expneurol.2008.01.017","article-title":"NK and CD4+ T cell changes in blood after seizures in temporal lobe epilepsy","volume":"211","author":"Bauer","year":"2008","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.seizure.2013.03.006_bib0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eplepsyres.2009.05.009","article-title":"Etiology and site of temporal lobe epilepsy influence postictal cytokine release","volume":"86","author":"Bauer","year":"2009","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2013.03.006_bib0115","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE commission on therapeutic strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2013.03.006_bib0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jim.2004.01.028","article-title":"A novel flow cytometric assay focusing on perforin release mechanisms of cytotoxic T lymphocytes","volume":"289","author":"Weren","year":"2004","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.seizure.2013.03.006_bib0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.seizure.2013.03.006_bib0130","doi-asserted-by":"crossref","first-page":"21327","DOI":"10.1016\/S0021-9258(18)54636-6","article-title":"Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking","volume":"266","author":"Fukuda","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.seizure.2013.03.006_bib0135","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4049\/jimmunol.0902773","article-title":"CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions","volume":"184","author":"Suidan","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.seizure.2013.03.006_bib0140","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1528-1167.2011.03080.x","article-title":"Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures","volume":"52","author":"Marchi","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2013.03.006_bib0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awl318","article-title":"Blood\u2013brain barrier leakage may lead to progression of temporal lobe epilepsy","volume":"130","author":"Van Vliet","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2013.03.006_bib0150","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1528-1167.2007.00988.x","article-title":"Seizure-promoting effect of blood\u2013brain barrier disruption","volume":"48","author":"Marchi","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2013.03.006_bib0155","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm.1878","article-title":"A role for leukocyte\u2013endothelial adhesion mechanisms in epilepsy","volume":"14","author":"Fabene","year":"2008","journal-title":"Nature Medicine"},{"key":"10.1016\/j.seizure.2013.03.006_bib0160","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/nm1208-1309","article-title":"Brain inflammation initiates seizures","volume":"14","author":"Kleen","year":"2008","journal-title":"Nature Medicine"},{"key":"10.1016\/j.seizure.2013.03.006_bib0165","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1126\/science.1214277","article-title":"Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state","volume":"10","author":"Schietinger","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.seizure.2013.03.006_bib0170","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1083\/jcb.100.4.1284","article-title":"Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells","volume":"100","author":"Buckley","year":"1985","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.seizure.2013.03.006_bib0175","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1073\/pnas.90.6.2150","article-title":"Brain contains two forms of synaptic vesicle protein 2","volume":"90","author":"Bajjalieh","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.seizure.2013.03.006_bib0180","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1523\/JNEUROSCI.14-09-05223.1994","article-title":"Differential expression of synaptic vesicle protein 2 (SV2) isoform","volume":"14","author":"Bajjalieh","year":"1994","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.seizure.2013.03.006_bib0185","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/35087000","article-title":"SV2 modulates the size of the readily releasable pool of secretory vesicles","volume":"3","author":"Xu","year":"2001","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.seizure.2013.03.006_bib0190","doi-asserted-by":"crossref","first-page":"15268","DOI":"10.1073\/pnas.96.26.15268","article-title":"Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)","volume":"96","author":"Crowder","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111300071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111300071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:42:18Z","timestamp":1761010938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105913111300071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S105913111300071X"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2013.03.006","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levetiracetam but not valproate inhibits function of CD8+ T lymphocytes","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2013.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}